Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Myelopathy

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Myelopathy in 3 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tovar-y-Romo, LB1
Tapia, R1
Björkman, R1
Hallman, KM1
Hedner, J1
Hedner, T1
Henning, M1
Kwak, S1
Nakamura, R1

Other Studies

3 other studies available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Myelopathy

ArticleYear
Delayed administration of VEGF rescues spinal motor neurons from death with a short effective time frame in excitotoxic experimental models in vivo.
    ASN neuro, 2012, Mar-27, Volume: 4, Issue:2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Brain-Deriv

2012
Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P.
    Pain, 1994, Volume: 57, Issue:3

    Topics: Acetaminophen; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Arginine; Behavior

1994
Acute and late neurotoxicity in the rat spinal cord in vivo induced by glutamate receptor agonists.
    Journal of the neurological sciences, 1995, Volume: 129 Suppl

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Behavior, Animal; Excitatory Amin

1995